Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Lowered to $100.00 at HC Wainwright

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Lowered to $100.00 at HC Wainwright

HC Wainwright lowered their target price on shares of Ionis Pharmaceuticals from $115.00 to $100.00 and set a "buy" rating for the company in a research note on Tuesday.

Canaccord Genuity Group Has Lowered Expectations for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) had its price target cut by investment analysts at Canaccord Genuity Group from $95.00 to $85.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 46.32% from the […]